Innovative Eyewear (LUCY) Cash from Investing Activities (2021 - 2025)
Innovative Eyewear (LUCY) posted Cash from Investing Activities of $824870.0 for Q4 2025, up 5660.3% sequentially from -$14835.0 in Q3 2025, and up 1442.98% YoY from $53459.6 in Q4 2024.
Innovative Eyewear (LUCY) Cash from Investing Activities (2021 - 2025) Analysis & Trends
Innovative Eyewear has reported Cash from Investing Activities for 5 years, with the latest figure at $824870.0 in Q4 2025.
- Quarterly Cash from Investing Activities rose 1442.98% year-over-year to $824870.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.5 million (up 186.71% YoY) and the FY2025 annual result came in at $4.5 million, up 186.71% from the prior year.
- Cash from Investing Activities advanced to $824870.0 in Q4 2025 per LUCY's latest filing, from -$14835.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $4.9 million in Q1 2025 and troughed at -$5.0 million in Q3 2024.
- A 5-year average of -$65152.4 and a median of -$59547.5 in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities sank 13007.41% in 2023, then surged 5270.96% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$31208.0 in 2021, then plunged by 106.75% to -$64523.0 in 2022, then surged by 3215.05% to $2.0 million in 2023, then plunged by 103.06% to -$61421.0 in 2024, then jumped by 1442.98% to $824870.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $824870.0, -$14835.0, and -$1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Innovative Eyewear | 4.37 Mn | 1.91 Mn | 242,515.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 824,870.00 |
| Dec 31, 2025 | 824,870.00 |
| Sep 30, 2025 | -14,835.00 |
| Sep 30, 2025 | -14,835.00 |
| Jun 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.27 Mn |
| Mar 31, 2025 | 4.94 Mn |
| Mar 31, 2025 | 4.94 Mn |
| Dec 31, 2024 | -61,421.00 |
| Dec 31, 2024 | -61,421.00 |
| Sep 30, 2024 | -4.99 Mn |
| Sep 30, 2024 | -4.99 Mn |
| Jun 30, 2024 | -18,273.00 |
| Jun 30, 2024 | -18,273.00 |
| Mar 31, 2024 | -95,538.00 |
| Mar 31, 2024 | -95,538.00 |
| Dec 31, 2023 | 2.01 Mn |
| Dec 31, 2023 | 2.01 Mn |
| Sep 30, 2023 | -93,417.00 |
| Sep 30, 2023 | -93,417.00 |